World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
42
Citations
8097
World Ranking
5331
National Ranking
2024

Overview

Hannah L. Turner is affiliated with the Scripps Research Institute in the United States. Their research focuses primarily on the fields of Medicine and Immunology and Microbiology, with significant contributions in Infectious Diseases, Immunology, Radiology, Nuclear Medicine and Imaging, Epidemiology, and Molecular Biology.

Their work spans several key topics including:

  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Influenza Virus Research Studies
  • Viral gastroenteritis research and epidemiology
  • Immunotherapy and Immune Responses
  • Animal Virus Infections Studies

Turner has authored multiple papers with notable publications in prestigious journals. Some recent examples include:

  • Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate, 2020, Science
  • Engineered immunogen binding to alum adjuvant enhances humoral immunity, 2020, Nature Medicine
  • Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection, 2021, Cell
  • Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines, 2020, Cell Reports
  • Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization, 2020, Immunity

Turner frequently collaborates with several researchers, including:

  • Andrew B. Ward
  • Gabriel Ozorowski
  • Dennis R. Burton
  • Rogier W. Sanders
  • Ian A. Wilson

Their publications most commonly appear in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Pathogens
  • Journal of Clinical Investigation
  • Nature Medicine
  • Cell Reports

Best Publications

  • Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

    Jesper Pallesen;Nianshuang Wang;Kizzmekia S. Corbett;Daniel Wrapp

  • Pre-fusion structure of a human coronavirus spike protein

    Robert N. Kirchdoerfer;Christopher A. Cottrell;Nianshuang Wang;Jesper Pallesen

  • Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis.

    Robert N. Kirchdoerfer;Nianshuang Wang;Jesper Pallesen;Daniel Wrapp;Daniel Wrapp

  • Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.

    Sandhya Bangaru;Gabriel Ozorowski;Hannah L Turner;Aleksandar Antanasijevic

  • A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface

    Sandhya Bangaru;Shanshan Lang;Michael Schotsaert;Hillary A. Vanderven

  • Engineered immunogen binding to alum adjuvant enhances humoral immunity

    Tyson J. Moyer;Tyson J. Moyer;Yu Kato;Yu Kato;Wuhbet Abraham;Jason Y. H. Chang

  • Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak

    Zachary A. Bornholdt;Hannah L. Turner;Charles D. Murin;Wen Li

  • Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization

    Matteo Bianchi;Hannah L. Turner;Bartek Nogal;Christopher A. Cottrell

  • Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.

    N.S. Laursen;R.H.E. Friesen;X. Zhu;M. Jongeneelen

  • Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection

    Erica Ollmann Saphire;Sharon L. Schendel;Marnie L. Fusco;Karthik Gangavarapu

  • Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.

    Philip J.M. Brouwer;Mitch Brinkkemper;Pauline Maisonnasse;Nathalie Dereuddre-Bosquet

  • Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection

    Andrew I. Flyak;Xiaoli Shen;Charles D. Murin;Hannah L. Turner

  • Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.

    Kristen E Pascal;Drew Dudgeon;John C Trefry;Manu Anantpadma

  • Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses

    Anna Z. Wec;Andrew S. Herbert;Charles D. Murin;Elisabeth K. Nyakatura

  • Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability

    Xuelian Zhao;Katie A. Howell;Shihua He;Shihua He;Jennifer M. Brannan

  • Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.

    Viktoriya Dubrovskaya;Karen Tran;Gabriel Ozorowski;Javier Guenaga

  • Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.

    Jesper Pallesen;Charles D. Murin;Natalia de Val;Christopher A. Cottrell

  • Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines.

    Bartek Nogal;Matteo Bianchi;Christopher A. Cottrell;Robert N. Kirchdoerfer

  • Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis.

    Robert N. Kirchdoerfer;Nianshuang Wang;Jesper Pallesen;Daniel Wrapp;Daniel Wrapp

  • Glycosylation of Human IgA Directly Inhibits Influenza A and Other Sialic-Acid-Binding Viruses

    Michael A. Maurer;Larissa Meyer;Matteo Bianchi;Hannah L. Turner

  • Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics

    Katie L. Winarski;Juanjie Tang;Laura Klenow;Jeehyun Lee

Frequent Co-Authors

Andrew B. Ward
Andrew B. Ward Scripps Research Institute
James E. Crowe
James E. Crowe Vanderbilt University Medical Center
Jason S. McLellan
Jason S. McLellan The University of Texas at Austin
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Ian A. Wilson
Ian A. Wilson Scripps Research Institute
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology
Rogier W. Sanders
Rogier W. Sanders University of Amsterdam
Sheng Li
Sheng Li University of California, San Diego
Xiangguo Qiu
Xiangguo Qiu Public Health Agency of Canada
Benjamin J. Doranz
Benjamin J. Doranz University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens numerous career doors in healthcare, research, and technology. For those interested in expanding their expertise and impact, pursuing specialized online degrees can be a strategic move. For example, becoming a Functional Medicine Nurse Practitioner can be achieved through dedicated functional medicine np programs, blending holistic health principles with clinical practice.

Another promising avenue is the healthcare information sector, where professionals manage critical data that drives patient care and research. Obtaining a professional coder certification can boost career prospects in medical coding, which requires precision and detailed understanding of healthcare terminology.

For those who aim to oversee healthcare data systems, roles like health information managers combine administrative and technical skills. The growing demand for qualified personnel is reflected in health information management jobs salary trends, which indicate competitive compensation and job stability.

To prepare for such roles, students should consider enrolling in accredited programs. The list of online cahiim accredited health information management degree options provides flexible and reputable pathways for gaining essential knowledge and credentials from anywhere.

Best Scientists Citing Hannah L. Turner

Trending Scientists

Recently Published Articles